Search results
Found 242 matches for
Many congratulations to Dr Robert Beagrie, a postdoc in the research group of Prof Doug Higgs at the MRC Molecular Haematology Unit (Radcliffe Department of Medicine)! Robert was a awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship, a four-year award that offers recently qualified postdoctoral researchers the opportunity to start independent research careers.
Simmons Group: Intestinal Immunology Lab
MRC HIU
We use state-of the-art molecular and computational approaches to understand mechanisms of intestinal immunity and how those go wrong in the inflammatory bowel diseases, Crohn’s disease and Ulcerative Colitis.
Ho Group: Translational Lung Immunology
MRC HIU
We are interested in how immunological responses impact on mechanisms of lung injury and repair.
Bannard Group: B Cell Immunology
MRC HIU
We study the cellular interactions and molecular events that lead to the development of high affinity and protective antibodies during humoral immune responses. Our main focus is the germinal centre reaction.
Jackson Group: Lymphatic Trafficking Research Group
MRC HIU
We focus on the mechanisms controlling the migration of leucocytes and tumour cells via lymph in health and disease.
Newbold Group: Molecular Parasitology
MRC HIU
Our group's interests centre on the role of multi-gene families in malaria in pathogenesis, immune evasion and their evolution.
Developmental Immunology Research Group
MRC HIU
This group is headed up by Professor G. Hollander who specialises in the molecular and cellular control of thymus development and function.
Davis Group: T-cell Biology Group
MRC HIU
We are interested in how lymphocytes decide to mount immune responses against, for example, tumours. This involves trying to understanding how leukocyte receptors, such as the T-cell receptor and immune checkpoints, are triggered.
Dong Group: Human T cell responses against Viruses & Cancer
MRC HIU
Our group focuses on determining the factors which affect T cells both in the control of viral infection and in the development of cancer.
Drakesmith Group: Iron and Immunity
MRC HIU
We are investigating how iron and anaemia influence immunity and infectious diseases. Our research inspires treatments that control iron physiology to benefit the host at the expense of pathogens.
Eggeling Group
MRC HIU
We apply and optimize advanced optical microscopy techniques, such as super-resolution STED microscopy, to decipher molecular dynamics in an unprecedented way. Our main focus is molecular plasma membrane organization, especially following immune responses.
Ogg Group: Cutaneous Immunology Group
MRC HIU
The aim of the group is to understand, at the molecular and cellular level, the role of human cutaneous immune responses in mechanisms of disease, treatment and vaccination. As well as contributing to an understanding of disease pathogenesis, we aim to translate our findings to changes in clinical practice.
Oxford Centre for Neuroinflammation
MRC HIU
We bring together biomedical, analytical and clinical expertise to shed new light on the causes that underpin neurodegenerative diseases.
Multi-dimensional Innate and Adaptive lmmune responses
MRC HIU
We focus on gaining a better understanding of the mechanisms that control the cell-cell interplay required for optimal expansion and activation of tumour-specific T cell populations and to apply this knowledge to the development of better treatment strategies in cancer patients.
Cornall Group: B cell development and immune regulation
MRC HIU
Our aims are to understand B cell development and diseases associated with abnormal antibody production. Inadequate or excessive immune responses lead to immunodeficiency or autoimmune and inflammatory diseases, which place a major economic and social burden on world health and the quality of human life. So, we are interested in the normal processes of immune function and how individuals vary due to inherited or acquired differences.